Owning 31% shares,hedge funds owners seem interested in Ovid Therapeutics Inc. (NASDAQ:OVID),

Key Insights Significantly high institutional ownership implies Ovid Therapeutics' stock price is sensitive to their...

Related Keywords

Jeremy Levin ,Ovid Therapeutics Inc ,Public Company Ownership ,Takeda Pharmaceutical Company ,Covid Therapeutic ,Ovid Therapeutics ,Takeda Pharmaceutical Company Limited ,Nstitutional Ownership ,Hedge Funds ,Shareholders ,Ndividual Investors ,Institutional Investors ,Nsider Ownership ,Nalyst Forecasts ,